ATE509633T1 - Verwendung eines amid-derivats des ge 2270 faktors a3 für die behandlung von akne - Google Patents

Verwendung eines amid-derivats des ge 2270 faktors a3 für die behandlung von akne

Info

Publication number
ATE509633T1
ATE509633T1 AT03759919T AT03759919T ATE509633T1 AT E509633 T1 ATE509633 T1 AT E509633T1 AT 03759919 T AT03759919 T AT 03759919T AT 03759919 T AT03759919 T AT 03759919T AT E509633 T1 ATE509633 T1 AT E509633T1
Authority
AT
Austria
Prior art keywords
acne
factor
treatment
amide derivative
amide
Prior art date
Application number
AT03759919T
Other languages
English (en)
Inventor
Adriano Malabarba
Marco Cavaleri
Giorgio Mosconi
Daniela Jabes
Gabriella Romano'
Original Assignee
Naicons S C A R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Naicons S C A R L filed Critical Naicons S C A R L
Application granted granted Critical
Publication of ATE509633T1 publication Critical patent/ATE509633T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03759919T 2002-06-17 2003-06-06 Verwendung eines amid-derivats des ge 2270 faktors a3 für die behandlung von akne ATE509633T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02013268 2002-06-17
PCT/EP2003/005989 WO2003105881A1 (en) 2002-06-17 2003-06-06 Use of amide derivative of ge 2270 factor a3 for the treatment of acne

Publications (1)

Publication Number Publication Date
ATE509633T1 true ATE509633T1 (de) 2011-06-15

Family

ID=29724391

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03759919T ATE509633T1 (de) 2002-06-17 2003-06-06 Verwendung eines amid-derivats des ge 2270 faktors a3 für die behandlung von akne

Country Status (17)

Country Link
US (1) US7655676B2 (de)
EP (1) EP1553967B1 (de)
JP (1) JP4723857B2 (de)
KR (1) KR20050026401A (de)
AR (1) AR039682A1 (de)
AT (1) ATE509633T1 (de)
AU (1) AU2003242647B2 (de)
BR (1) BR0305070A (de)
CA (1) CA2489705C (de)
CY (1) CY1111734T1 (de)
DK (1) DK1553967T3 (de)
ES (1) ES2364269T3 (de)
NO (1) NO333162B1 (de)
PT (1) PT1553967E (de)
SI (1) SI1553967T1 (de)
TW (1) TWI329650B (de)
WO (1) WO2003105881A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR060977A1 (es) 2006-05-31 2008-07-23 Novartis Ag Aminotiazoles y sus usos
ATE500259T1 (de) 2006-12-20 2011-03-15 Novartis Ag Aminothiazolmakrocyclen, ihre verwendung als antibakterielle verbindungen und verfahren zu ihrer herstellung
EA200901613A1 (ru) 2007-06-04 2010-06-30 Новартис Аг Макроциклы и их применение
NZ585788A (en) 2007-12-12 2011-07-29 Novartis Ag Aminothiazoles and their uses
PT106679B (pt) 2012-11-27 2015-03-25 Hovione Farmaciencia Sa Formulações tópicas de tetraciclinas, sua preparação e usos
FR3004939B1 (fr) * 2013-04-26 2015-05-22 Oreal Huile essentielle de satureja montana a forte teneur en geraniol, et utilisation pour traiter les peaux grasses et/ou les defauts esthetiques associes
DE102013215828A1 (de) * 2013-08-09 2015-02-12 Beiersdorf Ag Gelförmiges Sonnenschutzmittel mit Fettalkoholen

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU86865A1 (fr) * 1987-05-06 1989-01-19 Oreal Nouveaux retinoates d'ammonium quaternaires,leur utilisation en cosmetique et en dermopharmacie
DE365519T1 (de) * 1987-06-12 1990-09-06 Molecular Design International, Inc. Topische vorstufen von arzneimitteln zur behandlung von akne und hautkrankheiten.
DK0406745T3 (da) * 1989-07-04 1995-02-27 Lepetit Spa Antibiotiske GE 2270 faktorer A1, A2, A3 og H
JP2693859B2 (ja) * 1990-09-28 1997-12-24 高砂香料工業株式会社 尋常性▲ざ▼瘡用皮膚外用剤
IL100572A (en) * 1991-01-03 1997-01-10 Lepetit Spa Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them
JP2907640B2 (ja) 1992-06-29 1999-06-21 高砂香料工業株式会社 尋常性ざ瘡用皮膚外用剤
JP2937667B2 (ja) * 1992-11-19 1999-08-23 高砂香料工業株式会社 尋常性ざ瘡用皮膚外用剤
KR100381688B1 (ko) * 1995-02-07 2003-12-11 바이오써치 이탈리아 에스.피.에이. Ge2270및ge2270-유사항생제의염기성프롤린-아미드유도체
CA2242067A1 (en) * 1996-02-14 1997-08-21 Versicor Inc. Derivatives of antibiotic ge2270 factors c2a, d2 and e
AUPN892496A0 (en) * 1996-03-25 1996-04-18 Technical Consultancy Services Pty Limited Acne treatment
US6009225A (en) * 1998-05-26 1999-12-28 Ray; Craig D. Fiber optic drop splice closure and related methods

Also Published As

Publication number Publication date
ES2364269T3 (es) 2011-08-30
KR20050026401A (ko) 2005-03-15
TWI329650B (en) 2010-09-01
BR0305070A (pt) 2004-09-21
AU2003242647A1 (en) 2003-12-31
CA2489705A1 (en) 2003-12-24
TW200402425A (en) 2004-02-16
DK1553967T3 (da) 2011-08-29
PT1553967E (pt) 2011-08-01
AR039682A1 (es) 2005-03-09
WO2003105881A1 (en) 2003-12-24
CY1111734T1 (el) 2015-10-07
EP1553967B1 (de) 2011-05-18
CA2489705C (en) 2012-08-14
AU2003242647B2 (en) 2009-10-22
EP1553967A1 (de) 2005-07-20
JP4723857B2 (ja) 2011-07-13
NO20040662L (no) 2004-04-05
HK1074402A1 (en) 2005-11-11
US20070117825A1 (en) 2007-05-24
US7655676B2 (en) 2010-02-02
JP2005529947A (ja) 2005-10-06
SI1553967T1 (sl) 2011-07-29
NO333162B1 (no) 2013-03-25

Similar Documents

Publication Publication Date Title
DE60316538D1 (de) Dihydrobenzodiazepin-2-on-derivative für die behandlung von neurologischen erkrankungen
ATE350375T1 (de) 17beta-hydroxysteroid dehydrogenase type 3 inhibitoren zur behandlung von androgen- abhängigen erkrankungen
DE60325770D1 (de) Verwendung von rimexolon zur behandlung von augentrockenheit
ATE390407T1 (de) Phenethanolamin-derivate zur behandlung von atemwegserkrankungen
ATE410430T1 (de) 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose
ATE288431T1 (de) Substituierte bizyklische derivate für die behandlung von unnormalem zellwachstum
DE60233414D1 (de) Kombinationen für die behandlung entzündlicher erkrankungen
EP1643986A4 (de) Phenylcarboxylat-beta-secretase-hemmer zur behandlung von morbus alzheimer
ATE384699T1 (de) 2,6-chinolinyl- und 2,6-naphthylderivate und deren verwendungen zur behandlung von vla-4 bezogenen krankheiten
ATE502642T1 (de) Kombinationen für die behandlung von immun- entzündlichen erkrankungen
AU2003238007A8 (en) Methods of treating alzheimer's disease using aryl alkanoic acid amides
ATE446285T1 (de) Für die behandlung von alzheimer-krankheit und ähnlichen leiden geeignete 1-alkyl-3- thiosubstituierte indol-2-alkinsäuren
ATE427928T1 (de) Fluorobenzamide zur behandlung von alzheimer oder seniler dementia
DE602004023721D1 (de) Zusammensetzungen und methoden für die behandlung von herzerkrankungen
EP1651237A4 (de) Verfahren zur behandlung von dermatologischen erkrankungen
MY142270A (en) New process for the synthesis of (7-methoxy-1-naphthyl)acetonitrile and application in the synthesis of agomelatine
DE60335083D1 (de) Derivate von alpha-phenylthiocarbon- und alpha-phenyloxycarbonsäuren, die für die behandlung von auf die aktivierung von ppar alpha ansprechende krankheiten geeignet sind
ATE509633T1 (de) Verwendung eines amid-derivats des ge 2270 faktors a3 für die behandlung von akne
DE50205466D1 (de) Substituierte 2,5-diamidoindole als ece-inhibitoren zur behandlung von kardiovaskulären erkrankungen
DE60307086D1 (de) Zusammensetzng auf diclofenac-basis für die topische behandlung von erkrankungen des oropharynx
ATE444283T1 (de) Geschützte 3,5-dihydroxy-2,2-dimethyl- valeronitrile für die synthese von epothilonen- und derivaten und verfahren zur herstellung und die verwendung
ATE410166T1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin- derivate zur behandlung von unfruchtbarkeit
ATE510543T1 (de) Verwendung cilobradines oder seiner pharmazeutisch annehmbaren salze für die behandlung oder prävention von herzinsuffizienz
ATE395062T1 (de) Kombination von opioiden und einem piperazin- derivat für die behandlung von schmerzen
DE50307382D1 (de) Piezoaktor und verfahren zum herstellen des piezoaktors

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1553967

Country of ref document: EP